Boston, MA 06/24/2014 (wallstreetpr) – OHR Pharmaceutical Inc (NASDAQ:OHRP), the pharmaceutical company which focuses on research and development in ophthalmology, announced hosting a conference call and webcast on June 24, 2014. The call is scheduled to be held on Tuesday, 8:30 p.m. Eastern Time. Phase II Study Data OHR Pharmaceutical Inc (NASDAQ:OHRP) seeks to discuss the results […]
